A patient has severe P. falciparum malaria and is unable to tolerate oral medications. Which regimen is the U.S. Food and Drug Administration (FDA)approved treatment of choice for this patient?
a) Intravenous quinidine gluconate plus intravenous doxycycline Vibramycin
b) Intravenous artesunate followed by atovaquone/proguanil Malarone
c) Intravenous quinine Qualaquin plus intravenous clindamycin
d) Intravenous mefloquine plus intravenous primaquine
Question 2
A patient who frequently travels to Africa has been treated for an acute attack of P. vivax malaria. The patient asks the nurse about medications to prevent relapse. Which response by the nurse is correct?
a) The form of malaria that you have does not relapse after a clinical cure has been achieved.
b) Until you are no longer traveling to Africa, relapse drugs will be postponed.
c) Using mosquito netting and DEET when you travel will prevent relapse.
d) You will be given prophylactic medications when you travel to prevent relapse.
A medical assistant listening to the patient and physician discuss the patient's care.
Preparing a Manual Patient Ledger.
Positioning the Patient in the Supine Position
Instructing the Patient in Collecting a Stool Specimen
A pacemaker in a patient’s chest.
Life cycle of a Plasmodium species that causes malaria